Result of FASTA (omim) for pFN21AE6436
FASTA searches a protein or DNA sequence data bank 36.3.4 Apr, 2011
Please cite:
W.R. Pearson & D.J. Lipman PNAS (1988) 85:2444-2448

Query: pF1KE6436, 460 aa
  1>>>pF1KE6436 460 - 460 aa - 460 aa
Library: /omim/omim.rfq.tfa
  60827320 residues in 85289 sequences

Statistics:  Expectation_n fit: rho(ln(x))= 5.0789+/-0.000363; mu= 18.6439+/- 0.023
 mean_var=64.7444+/-12.910, 0's: 0 Z-trim(112.0): 48  B-trim: 0 in 0/57
 Lambda= 0.159394
 statistics sampled from 20745 (20793) to 20745 sequences
Algorithm: FASTA (3.7 Nov 2010) [optimized]
Parameters: BL50 matrix (15:-5), open/ext: -10/-2
 ktup: 2, E-join: 1 (0.62), E-opt: 0.2 (0.244), width:  16
 Scan time:  9.220

The best scores are:                                      opt bits E(85289)
XP_005270461 (OMIM: 608353) PREDICTED: antizyme in ( 460) 3114 725.2 8.9e-209
NP_443724 (OMIM: 608353) antizyme inhibitor 2 isof ( 460) 3114 725.2 8.9e-209
NP_001280491 (OMIM: 608353) antizyme inhibitor 2 i ( 460) 3114 725.2 8.9e-209
XP_011538859 (OMIM: 608353) PREDICTED: antizyme in ( 402) 2529 590.6 2.5e-168
XP_005270463 (OMIM: 608353) PREDICTED: antizyme in ( 402) 2529 590.6 2.5e-168
XP_016855662 (OMIM: 608353) PREDICTED: antizyme in ( 365) 2492 582.1 8.4e-166
XP_016855658 (OMIM: 608353) PREDICTED: antizyme in ( 365) 2492 582.1 8.4e-166
XP_005270464 (OMIM: 608353) PREDICTED: antizyme in ( 365) 2492 582.1 8.4e-166
NP_001288753 (OMIM: 608353) antizyme inhibitor 2 i ( 365) 2492 582.1 8.4e-166
XP_016855657 (OMIM: 608353) PREDICTED: antizyme in ( 365) 2492 582.1 8.4e-166
XP_016855664 (OMIM: 608353) PREDICTED: antizyme in ( 365) 2492 582.1 8.4e-166
XP_016855659 (OMIM: 608353) PREDICTED: antizyme in ( 365) 2492 582.1 8.4e-166
NP_001288752 (OMIM: 608353) antizyme inhibitor 2 i ( 365) 2492 582.1 8.4e-166
XP_016855661 (OMIM: 608353) PREDICTED: antizyme in ( 365) 2492 582.1 8.4e-166
XP_016855660 (OMIM: 608353) PREDICTED: antizyme in ( 365) 2492 582.1 8.4e-166
XP_016855656 (OMIM: 608353) PREDICTED: antizyme in ( 380) 2275 532.2 9.1e-151
XP_011538865 (OMIM: 608353) PREDICTED: antizyme in ( 362) 2269 530.8 2.3e-150
NP_001288755 (OMIM: 608353) antizyme inhibitor 2 i ( 362) 2269 530.8 2.3e-150
XP_016855665 (OMIM: 608353) PREDICTED: antizyme in ( 309) 2125 497.7 1.9e-140
XP_016855666 (OMIM: 608353) PREDICTED: antizyme in ( 309) 2125 497.7 1.9e-140
XP_016855667 (OMIM: 608353) PREDICTED: antizyme in ( 309) 2125 497.7 1.9e-140
XP_006710375 (OMIM: 608353) PREDICTED: antizyme in ( 309) 2125 497.7 1.9e-140
XP_011538868 (OMIM: 608353) PREDICTED: antizyme in ( 357) 2009 471.0 2.3e-132
XP_016855663 (OMIM: 608353) PREDICTED: antizyme in ( 358) 2009 471.0 2.3e-132
NP_001288754 (OMIM: 608353) antizyme inhibitor 2 i ( 480) 2009 471.1 2.9e-132
NP_002530 (OMIM: 165640) ornithine decarboxylase i ( 461) 1569 369.9  8e-102
NP_001274119 (OMIM: 165640) ornithine decarboxylas ( 461) 1569 369.9  8e-102
NP_001274118 (OMIM: 165640) ornithine decarboxylas ( 461) 1569 369.9  8e-102
XP_011515428 (OMIM: 607909) PREDICTED: antizyme in ( 448) 1271 301.4 3.3e-81
NP_680479 (OMIM: 607909) antizyme inhibitor 1 isof ( 448) 1271 301.4 3.3e-81
NP_056962 (OMIM: 607909) antizyme inhibitor 1 isof ( 448) 1271 301.4 3.3e-81
XP_011515429 (OMIM: 607909) PREDICTED: antizyme in ( 448) 1271 301.4 3.3e-81
XP_005251026 (OMIM: 607909) PREDICTED: antizyme in ( 447) 1269 300.9 4.5e-81
XP_016869053 (OMIM: 607909) PREDICTED: antizyme in ( 447) 1269 300.9 4.5e-81
XP_016869052 (OMIM: 607909) PREDICTED: antizyme in ( 447) 1269 300.9 4.5e-81
NP_001288597 (OMIM: 607909) antizyme inhibitor 1 i ( 363) 1127 268.2 2.6e-71
NP_001274117 (OMIM: 165640) ornithine decarboxylas ( 332) 1124 267.5 3.9e-71
XP_016869054 (OMIM: 607909) PREDICTED: antizyme in ( 281)  790 190.6 4.5e-48
XP_011515430 (OMIM: 607909) PREDICTED: antizyme in ( 281)  790 190.6 4.5e-48
XP_016869055 (OMIM: 607909) PREDICTED: antizyme in ( 280)  788 190.2 6.2e-48


>>XP_005270461 (OMIM: 608353) PREDICTED: antizyme inhibi  (460 aa)
 initn: 3114 init1: 3114 opt: 3114  Z-score: 3869.2  bits: 725.2 E(85289): 8.9e-209
Smith-Waterman score: 3114; 100.0% identity (100.0% similar) in 460 aa overlap (1-460:1-460)

               10        20        30        40        50        60
pF1KE6 MAGYLSESDFVMVEEGFSTRDLLKELTLGASQATTDEVAAFFVADLGAIVRKHFCFLKCL
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_005 MAGYLSESDFVMVEEGFSTRDLLKELTLGASQATTDEVAAFFVADLGAIVRKHFCFLKCL
               10        20        30        40        50        60

               70        80        90       100       110       120
pF1KE6 PRVRPFYAVKCNSSPGVLKVLAQLGLGFSCANKAEMELVQHIGIPASKIICANPCKQIAQ
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_005 PRVRPFYAVKCNSSPGVLKVLAQLGLGFSCANKAEMELVQHIGIPASKIICANPCKQIAQ
               70        80        90       100       110       120

              130       140       150       160       170       180
pF1KE6 IKYAAKHGIQLLSFDNEMELAKVVKSHPSAKMVLCIATDDSHSLSCLSLKFGVSLKSCRH
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_005 IKYAAKHGIQLLSFDNEMELAKVVKSHPSAKMVLCIATDDSHSLSCLSLKFGVSLKSCRH
              130       140       150       160       170       180

              190       200       210       220       230       240
pF1KE6 LLENAKKHHVEVVGVSFHIGSGCPDPQAYAQSIADARLVFEMGTELGHKMHVLDLGGGFP
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_005 LLENAKKHHVEVVGVSFHIGSGCPDPQAYAQSIADARLVFEMGTELGHKMHVLDLGGGFP
              190       200       210       220       230       240

              250       260       270       280       290       300
pF1KE6 GTEGAKVRFEEIASVINSALDLYFPEGCGVDIFAELGRYYVTSAFTVAVSIIAKKEVLLD
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_005 GTEGAKVRFEEIASVINSALDLYFPEGCGVDIFAELGRYYVTSAFTVAVSIIAKKEVLLD
              250       260       270       280       290       300

              310       320       330       340       350       360
pF1KE6 QPGREEENGSTSKTIVYHLDEGVYGIFNSVLFDNICPTPILQKKPSTEQPLYSSSLWGPA
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_005 QPGREEENGSTSKTIVYHLDEGVYGIFNSVLFDNICPTPILQKKPSTEQPLYSSSLWGPA
              310       320       330       340       350       360

              370       380       390       400       410       420
pF1KE6 VDGCDCVAEGLWLPQLHVGDWLVFDNMGAYTVGMGSPFWGTQACHITYAMSRVAWEALRR
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_005 VDGCDCVAEGLWLPQLHVGDWLVFDNMGAYTVGMGSPFWGTQACHITYAMSRVAWEALRR
              370       380       390       400       410       420

              430       440       450       460
pF1KE6 QLMAAEQEDDVEGVCKPLSCGWEITDTLCVGPVFTPASIM
       ::::::::::::::::::::::::::::::::::::::::
XP_005 QLMAAEQEDDVEGVCKPLSCGWEITDTLCVGPVFTPASIM
              430       440       450       460

>>NP_443724 (OMIM: 608353) antizyme inhibitor 2 isoform   (460 aa)
 initn: 3114 init1: 3114 opt: 3114  Z-score: 3869.2  bits: 725.2 E(85289): 8.9e-209
Smith-Waterman score: 3114; 100.0% identity (100.0% similar) in 460 aa overlap (1-460:1-460)

               10        20        30        40        50        60
pF1KE6 MAGYLSESDFVMVEEGFSTRDLLKELTLGASQATTDEVAAFFVADLGAIVRKHFCFLKCL
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_443 MAGYLSESDFVMVEEGFSTRDLLKELTLGASQATTDEVAAFFVADLGAIVRKHFCFLKCL
               10        20        30        40        50        60

               70        80        90       100       110       120
pF1KE6 PRVRPFYAVKCNSSPGVLKVLAQLGLGFSCANKAEMELVQHIGIPASKIICANPCKQIAQ
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_443 PRVRPFYAVKCNSSPGVLKVLAQLGLGFSCANKAEMELVQHIGIPASKIICANPCKQIAQ
               70        80        90       100       110       120

              130       140       150       160       170       180
pF1KE6 IKYAAKHGIQLLSFDNEMELAKVVKSHPSAKMVLCIATDDSHSLSCLSLKFGVSLKSCRH
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_443 IKYAAKHGIQLLSFDNEMELAKVVKSHPSAKMVLCIATDDSHSLSCLSLKFGVSLKSCRH
              130       140       150       160       170       180

              190       200       210       220       230       240
pF1KE6 LLENAKKHHVEVVGVSFHIGSGCPDPQAYAQSIADARLVFEMGTELGHKMHVLDLGGGFP
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_443 LLENAKKHHVEVVGVSFHIGSGCPDPQAYAQSIADARLVFEMGTELGHKMHVLDLGGGFP
              190       200       210       220       230       240

              250       260       270       280       290       300
pF1KE6 GTEGAKVRFEEIASVINSALDLYFPEGCGVDIFAELGRYYVTSAFTVAVSIIAKKEVLLD
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_443 GTEGAKVRFEEIASVINSALDLYFPEGCGVDIFAELGRYYVTSAFTVAVSIIAKKEVLLD
              250       260       270       280       290       300

              310       320       330       340       350       360
pF1KE6 QPGREEENGSTSKTIVYHLDEGVYGIFNSVLFDNICPTPILQKKPSTEQPLYSSSLWGPA
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_443 QPGREEENGSTSKTIVYHLDEGVYGIFNSVLFDNICPTPILQKKPSTEQPLYSSSLWGPA
              310       320       330       340       350       360

              370       380       390       400       410       420
pF1KE6 VDGCDCVAEGLWLPQLHVGDWLVFDNMGAYTVGMGSPFWGTQACHITYAMSRVAWEALRR
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_443 VDGCDCVAEGLWLPQLHVGDWLVFDNMGAYTVGMGSPFWGTQACHITYAMSRVAWEALRR
              370       380       390       400       410       420

              430       440       450       460
pF1KE6 QLMAAEQEDDVEGVCKPLSCGWEITDTLCVGPVFTPASIM
       ::::::::::::::::::::::::::::::::::::::::
NP_443 QLMAAEQEDDVEGVCKPLSCGWEITDTLCVGPVFTPASIM
              430       440       450       460

>>NP_001280491 (OMIM: 608353) antizyme inhibitor 2 isofo  (460 aa)
 initn: 3114 init1: 3114 opt: 3114  Z-score: 3869.2  bits: 725.2 E(85289): 8.9e-209
Smith-Waterman score: 3114; 100.0% identity (100.0% similar) in 460 aa overlap (1-460:1-460)

               10        20        30        40        50        60
pF1KE6 MAGYLSESDFVMVEEGFSTRDLLKELTLGASQATTDEVAAFFVADLGAIVRKHFCFLKCL
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_001 MAGYLSESDFVMVEEGFSTRDLLKELTLGASQATTDEVAAFFVADLGAIVRKHFCFLKCL
               10        20        30        40        50        60

               70        80        90       100       110       120
pF1KE6 PRVRPFYAVKCNSSPGVLKVLAQLGLGFSCANKAEMELVQHIGIPASKIICANPCKQIAQ
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_001 PRVRPFYAVKCNSSPGVLKVLAQLGLGFSCANKAEMELVQHIGIPASKIICANPCKQIAQ
               70        80        90       100       110       120

              130       140       150       160       170       180
pF1KE6 IKYAAKHGIQLLSFDNEMELAKVVKSHPSAKMVLCIATDDSHSLSCLSLKFGVSLKSCRH
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_001 IKYAAKHGIQLLSFDNEMELAKVVKSHPSAKMVLCIATDDSHSLSCLSLKFGVSLKSCRH
              130       140       150       160       170       180

              190       200       210       220       230       240
pF1KE6 LLENAKKHHVEVVGVSFHIGSGCPDPQAYAQSIADARLVFEMGTELGHKMHVLDLGGGFP
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_001 LLENAKKHHVEVVGVSFHIGSGCPDPQAYAQSIADARLVFEMGTELGHKMHVLDLGGGFP
              190       200       210       220       230       240

              250       260       270       280       290       300
pF1KE6 GTEGAKVRFEEIASVINSALDLYFPEGCGVDIFAELGRYYVTSAFTVAVSIIAKKEVLLD
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_001 GTEGAKVRFEEIASVINSALDLYFPEGCGVDIFAELGRYYVTSAFTVAVSIIAKKEVLLD
              250       260       270       280       290       300

              310       320       330       340       350       360
pF1KE6 QPGREEENGSTSKTIVYHLDEGVYGIFNSVLFDNICPTPILQKKPSTEQPLYSSSLWGPA
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_001 QPGREEENGSTSKTIVYHLDEGVYGIFNSVLFDNICPTPILQKKPSTEQPLYSSSLWGPA
              310       320       330       340       350       360

              370       380       390       400       410       420
pF1KE6 VDGCDCVAEGLWLPQLHVGDWLVFDNMGAYTVGMGSPFWGTQACHITYAMSRVAWEALRR
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_001 VDGCDCVAEGLWLPQLHVGDWLVFDNMGAYTVGMGSPFWGTQACHITYAMSRVAWEALRR
              370       380       390       400       410       420

              430       440       450       460
pF1KE6 QLMAAEQEDDVEGVCKPLSCGWEITDTLCVGPVFTPASIM
       ::::::::::::::::::::::::::::::::::::::::
NP_001 QLMAAEQEDDVEGVCKPLSCGWEITDTLCVGPVFTPASIM
              430       440       450       460

>>XP_011538859 (OMIM: 608353) PREDICTED: antizyme inhibi  (402 aa)
 initn: 2529 init1: 2529 opt: 2529  Z-score: 3143.0  bits: 590.6 E(85289): 2.5e-168
Smith-Waterman score: 2589; 87.4% identity (87.4% similar) in 460 aa overlap (1-460:1-402)

               10        20        30        40        50        60
pF1KE6 MAGYLSESDFVMVEEGFSTRDLLKELTLGASQATTDEVAAFFVADLGAIVRKHFCFLKCL
       :::::::::::::::::::::::::::::::::::                         
XP_011 MAGYLSESDFVMVEEGFSTRDLLKELTLGASQATT-------------------------
               10        20        30                              

               70        80        90       100       110       120
pF1KE6 PRVRPFYAVKCNSSPGVLKVLAQLGLGFSCANKAEMELVQHIGIPASKIICANPCKQIAQ
                                        :::::::::::::::::::::::::::
XP_011 ---------------------------------AEMELVQHIGIPASKIICANPCKQIAQ
                                           40        50        60  

              130       140       150       160       170       180
pF1KE6 IKYAAKHGIQLLSFDNEMELAKVVKSHPSAKMVLCIATDDSHSLSCLSLKFGVSLKSCRH
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_011 IKYAAKHGIQLLSFDNEMELAKVVKSHPSAKMVLCIATDDSHSLSCLSLKFGVSLKSCRH
             70        80        90       100       110       120  

              190       200       210       220       230       240
pF1KE6 LLENAKKHHVEVVGVSFHIGSGCPDPQAYAQSIADARLVFEMGTELGHKMHVLDLGGGFP
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_011 LLENAKKHHVEVVGVSFHIGSGCPDPQAYAQSIADARLVFEMGTELGHKMHVLDLGGGFP
            130       140       150       160       170       180  

              250       260       270       280       290       300
pF1KE6 GTEGAKVRFEEIASVINSALDLYFPEGCGVDIFAELGRYYVTSAFTVAVSIIAKKEVLLD
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_011 GTEGAKVRFEEIASVINSALDLYFPEGCGVDIFAELGRYYVTSAFTVAVSIIAKKEVLLD
            190       200       210       220       230       240  

              310       320       330       340       350       360
pF1KE6 QPGREEENGSTSKTIVYHLDEGVYGIFNSVLFDNICPTPILQKKPSTEQPLYSSSLWGPA
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_011 QPGREEENGSTSKTIVYHLDEGVYGIFNSVLFDNICPTPILQKKPSTEQPLYSSSLWGPA
            250       260       270       280       290       300  

              370       380       390       400       410       420
pF1KE6 VDGCDCVAEGLWLPQLHVGDWLVFDNMGAYTVGMGSPFWGTQACHITYAMSRVAWEALRR
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_011 VDGCDCVAEGLWLPQLHVGDWLVFDNMGAYTVGMGSPFWGTQACHITYAMSRVAWEALRR
            310       320       330       340       350       360  

              430       440       450       460
pF1KE6 QLMAAEQEDDVEGVCKPLSCGWEITDTLCVGPVFTPASIM
       ::::::::::::::::::::::::::::::::::::::::
XP_011 QLMAAEQEDDVEGVCKPLSCGWEITDTLCVGPVFTPASIM
            370       380       390       400  

>>XP_005270463 (OMIM: 608353) PREDICTED: antizyme inhibi  (402 aa)
 initn: 2529 init1: 2529 opt: 2529  Z-score: 3143.0  bits: 590.6 E(85289): 2.5e-168
Smith-Waterman score: 2589; 87.4% identity (87.4% similar) in 460 aa overlap (1-460:1-402)

               10        20        30        40        50        60
pF1KE6 MAGYLSESDFVMVEEGFSTRDLLKELTLGASQATTDEVAAFFVADLGAIVRKHFCFLKCL
       :::::::::::::::::::::::::::::::::::                         
XP_005 MAGYLSESDFVMVEEGFSTRDLLKELTLGASQATT-------------------------
               10        20        30                              

               70        80        90       100       110       120
pF1KE6 PRVRPFYAVKCNSSPGVLKVLAQLGLGFSCANKAEMELVQHIGIPASKIICANPCKQIAQ
                                        :::::::::::::::::::::::::::
XP_005 ---------------------------------AEMELVQHIGIPASKIICANPCKQIAQ
                                           40        50        60  

              130       140       150       160       170       180
pF1KE6 IKYAAKHGIQLLSFDNEMELAKVVKSHPSAKMVLCIATDDSHSLSCLSLKFGVSLKSCRH
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_005 IKYAAKHGIQLLSFDNEMELAKVVKSHPSAKMVLCIATDDSHSLSCLSLKFGVSLKSCRH
             70        80        90       100       110       120  

              190       200       210       220       230       240
pF1KE6 LLENAKKHHVEVVGVSFHIGSGCPDPQAYAQSIADARLVFEMGTELGHKMHVLDLGGGFP
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_005 LLENAKKHHVEVVGVSFHIGSGCPDPQAYAQSIADARLVFEMGTELGHKMHVLDLGGGFP
            130       140       150       160       170       180  

              250       260       270       280       290       300
pF1KE6 GTEGAKVRFEEIASVINSALDLYFPEGCGVDIFAELGRYYVTSAFTVAVSIIAKKEVLLD
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_005 GTEGAKVRFEEIASVINSALDLYFPEGCGVDIFAELGRYYVTSAFTVAVSIIAKKEVLLD
            190       200       210       220       230       240  

              310       320       330       340       350       360
pF1KE6 QPGREEENGSTSKTIVYHLDEGVYGIFNSVLFDNICPTPILQKKPSTEQPLYSSSLWGPA
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_005 QPGREEENGSTSKTIVYHLDEGVYGIFNSVLFDNICPTPILQKKPSTEQPLYSSSLWGPA
            250       260       270       280       290       300  

              370       380       390       400       410       420
pF1KE6 VDGCDCVAEGLWLPQLHVGDWLVFDNMGAYTVGMGSPFWGTQACHITYAMSRVAWEALRR
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_005 VDGCDCVAEGLWLPQLHVGDWLVFDNMGAYTVGMGSPFWGTQACHITYAMSRVAWEALRR
            310       320       330       340       350       360  

              430       440       450       460
pF1KE6 QLMAAEQEDDVEGVCKPLSCGWEITDTLCVGPVFTPASIM
       ::::::::::::::::::::::::::::::::::::::::
XP_005 QLMAAEQEDDVEGVCKPLSCGWEITDTLCVGPVFTPASIM
            370       380       390       400  

>>XP_016855662 (OMIM: 608353) PREDICTED: antizyme inhibi  (365 aa)
 initn: 2492 init1: 2492 opt: 2492  Z-score: 3097.6  bits: 582.1 E(85289): 8.4e-166
Smith-Waterman score: 2492; 100.0% identity (100.0% similar) in 365 aa overlap (96-460:1-365)

          70        80        90       100       110       120     
pF1KE6 FYAVKCNSSPGVLKVLAQLGLGFSCANKAEMELVQHIGIPASKIICANPCKQIAQIKYAA
                                     ::::::::::::::::::::::::::::::
XP_016                               MELVQHIGIPASKIICANPCKQIAQIKYAA
                                             10        20        30

         130       140       150       160       170       180     
pF1KE6 KHGIQLLSFDNEMELAKVVKSHPSAKMVLCIATDDSHSLSCLSLKFGVSLKSCRHLLENA
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 KHGIQLLSFDNEMELAKVVKSHPSAKMVLCIATDDSHSLSCLSLKFGVSLKSCRHLLENA
               40        50        60        70        80        90

         190       200       210       220       230       240     
pF1KE6 KKHHVEVVGVSFHIGSGCPDPQAYAQSIADARLVFEMGTELGHKMHVLDLGGGFPGTEGA
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 KKHHVEVVGVSFHIGSGCPDPQAYAQSIADARLVFEMGTELGHKMHVLDLGGGFPGTEGA
              100       110       120       130       140       150

         250       260       270       280       290       300     
pF1KE6 KVRFEEIASVINSALDLYFPEGCGVDIFAELGRYYVTSAFTVAVSIIAKKEVLLDQPGRE
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 KVRFEEIASVINSALDLYFPEGCGVDIFAELGRYYVTSAFTVAVSIIAKKEVLLDQPGRE
              160       170       180       190       200       210

         310       320       330       340       350       360     
pF1KE6 EENGSTSKTIVYHLDEGVYGIFNSVLFDNICPTPILQKKPSTEQPLYSSSLWGPAVDGCD
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 EENGSTSKTIVYHLDEGVYGIFNSVLFDNICPTPILQKKPSTEQPLYSSSLWGPAVDGCD
              220       230       240       250       260       270

         370       380       390       400       410       420     
pF1KE6 CVAEGLWLPQLHVGDWLVFDNMGAYTVGMGSPFWGTQACHITYAMSRVAWEALRRQLMAA
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 CVAEGLWLPQLHVGDWLVFDNMGAYTVGMGSPFWGTQACHITYAMSRVAWEALRRQLMAA
              280       290       300       310       320       330

         430       440       450       460
pF1KE6 EQEDDVEGVCKPLSCGWEITDTLCVGPVFTPASIM
       :::::::::::::::::::::::::::::::::::
XP_016 EQEDDVEGVCKPLSCGWEITDTLCVGPVFTPASIM
              340       350       360     

>>XP_016855658 (OMIM: 608353) PREDICTED: antizyme inhibi  (365 aa)
 initn: 2492 init1: 2492 opt: 2492  Z-score: 3097.6  bits: 582.1 E(85289): 8.4e-166
Smith-Waterman score: 2492; 100.0% identity (100.0% similar) in 365 aa overlap (96-460:1-365)

          70        80        90       100       110       120     
pF1KE6 FYAVKCNSSPGVLKVLAQLGLGFSCANKAEMELVQHIGIPASKIICANPCKQIAQIKYAA
                                     ::::::::::::::::::::::::::::::
XP_016                               MELVQHIGIPASKIICANPCKQIAQIKYAA
                                             10        20        30

         130       140       150       160       170       180     
pF1KE6 KHGIQLLSFDNEMELAKVVKSHPSAKMVLCIATDDSHSLSCLSLKFGVSLKSCRHLLENA
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 KHGIQLLSFDNEMELAKVVKSHPSAKMVLCIATDDSHSLSCLSLKFGVSLKSCRHLLENA
               40        50        60        70        80        90

         190       200       210       220       230       240     
pF1KE6 KKHHVEVVGVSFHIGSGCPDPQAYAQSIADARLVFEMGTELGHKMHVLDLGGGFPGTEGA
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 KKHHVEVVGVSFHIGSGCPDPQAYAQSIADARLVFEMGTELGHKMHVLDLGGGFPGTEGA
              100       110       120       130       140       150

         250       260       270       280       290       300     
pF1KE6 KVRFEEIASVINSALDLYFPEGCGVDIFAELGRYYVTSAFTVAVSIIAKKEVLLDQPGRE
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 KVRFEEIASVINSALDLYFPEGCGVDIFAELGRYYVTSAFTVAVSIIAKKEVLLDQPGRE
              160       170       180       190       200       210

         310       320       330       340       350       360     
pF1KE6 EENGSTSKTIVYHLDEGVYGIFNSVLFDNICPTPILQKKPSTEQPLYSSSLWGPAVDGCD
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 EENGSTSKTIVYHLDEGVYGIFNSVLFDNICPTPILQKKPSTEQPLYSSSLWGPAVDGCD
              220       230       240       250       260       270

         370       380       390       400       410       420     
pF1KE6 CVAEGLWLPQLHVGDWLVFDNMGAYTVGMGSPFWGTQACHITYAMSRVAWEALRRQLMAA
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 CVAEGLWLPQLHVGDWLVFDNMGAYTVGMGSPFWGTQACHITYAMSRVAWEALRRQLMAA
              280       290       300       310       320       330

         430       440       450       460
pF1KE6 EQEDDVEGVCKPLSCGWEITDTLCVGPVFTPASIM
       :::::::::::::::::::::::::::::::::::
XP_016 EQEDDVEGVCKPLSCGWEITDTLCVGPVFTPASIM
              340       350       360     

>>XP_005270464 (OMIM: 608353) PREDICTED: antizyme inhibi  (365 aa)
 initn: 2492 init1: 2492 opt: 2492  Z-score: 3097.6  bits: 582.1 E(85289): 8.4e-166
Smith-Waterman score: 2492; 100.0% identity (100.0% similar) in 365 aa overlap (96-460:1-365)

          70        80        90       100       110       120     
pF1KE6 FYAVKCNSSPGVLKVLAQLGLGFSCANKAEMELVQHIGIPASKIICANPCKQIAQIKYAA
                                     ::::::::::::::::::::::::::::::
XP_005                               MELVQHIGIPASKIICANPCKQIAQIKYAA
                                             10        20        30

         130       140       150       160       170       180     
pF1KE6 KHGIQLLSFDNEMELAKVVKSHPSAKMVLCIATDDSHSLSCLSLKFGVSLKSCRHLLENA
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_005 KHGIQLLSFDNEMELAKVVKSHPSAKMVLCIATDDSHSLSCLSLKFGVSLKSCRHLLENA
               40        50        60        70        80        90

         190       200       210       220       230       240     
pF1KE6 KKHHVEVVGVSFHIGSGCPDPQAYAQSIADARLVFEMGTELGHKMHVLDLGGGFPGTEGA
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_005 KKHHVEVVGVSFHIGSGCPDPQAYAQSIADARLVFEMGTELGHKMHVLDLGGGFPGTEGA
              100       110       120       130       140       150

         250       260       270       280       290       300     
pF1KE6 KVRFEEIASVINSALDLYFPEGCGVDIFAELGRYYVTSAFTVAVSIIAKKEVLLDQPGRE
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_005 KVRFEEIASVINSALDLYFPEGCGVDIFAELGRYYVTSAFTVAVSIIAKKEVLLDQPGRE
              160       170       180       190       200       210

         310       320       330       340       350       360     
pF1KE6 EENGSTSKTIVYHLDEGVYGIFNSVLFDNICPTPILQKKPSTEQPLYSSSLWGPAVDGCD
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_005 EENGSTSKTIVYHLDEGVYGIFNSVLFDNICPTPILQKKPSTEQPLYSSSLWGPAVDGCD
              220       230       240       250       260       270

         370       380       390       400       410       420     
pF1KE6 CVAEGLWLPQLHVGDWLVFDNMGAYTVGMGSPFWGTQACHITYAMSRVAWEALRRQLMAA
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_005 CVAEGLWLPQLHVGDWLVFDNMGAYTVGMGSPFWGTQACHITYAMSRVAWEALRRQLMAA
              280       290       300       310       320       330

         430       440       450       460
pF1KE6 EQEDDVEGVCKPLSCGWEITDTLCVGPVFTPASIM
       :::::::::::::::::::::::::::::::::::
XP_005 EQEDDVEGVCKPLSCGWEITDTLCVGPVFTPASIM
              340       350       360     

>>NP_001288753 (OMIM: 608353) antizyme inhibitor 2 isofo  (365 aa)
 initn: 2492 init1: 2492 opt: 2492  Z-score: 3097.6  bits: 582.1 E(85289): 8.4e-166
Smith-Waterman score: 2492; 100.0% identity (100.0% similar) in 365 aa overlap (96-460:1-365)

          70        80        90       100       110       120     
pF1KE6 FYAVKCNSSPGVLKVLAQLGLGFSCANKAEMELVQHIGIPASKIICANPCKQIAQIKYAA
                                     ::::::::::::::::::::::::::::::
NP_001                               MELVQHIGIPASKIICANPCKQIAQIKYAA
                                             10        20        30

         130       140       150       160       170       180     
pF1KE6 KHGIQLLSFDNEMELAKVVKSHPSAKMVLCIATDDSHSLSCLSLKFGVSLKSCRHLLENA
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_001 KHGIQLLSFDNEMELAKVVKSHPSAKMVLCIATDDSHSLSCLSLKFGVSLKSCRHLLENA
               40        50        60        70        80        90

         190       200       210       220       230       240     
pF1KE6 KKHHVEVVGVSFHIGSGCPDPQAYAQSIADARLVFEMGTELGHKMHVLDLGGGFPGTEGA
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_001 KKHHVEVVGVSFHIGSGCPDPQAYAQSIADARLVFEMGTELGHKMHVLDLGGGFPGTEGA
              100       110       120       130       140       150

         250       260       270       280       290       300     
pF1KE6 KVRFEEIASVINSALDLYFPEGCGVDIFAELGRYYVTSAFTVAVSIIAKKEVLLDQPGRE
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_001 KVRFEEIASVINSALDLYFPEGCGVDIFAELGRYYVTSAFTVAVSIIAKKEVLLDQPGRE
              160       170       180       190       200       210

         310       320       330       340       350       360     
pF1KE6 EENGSTSKTIVYHLDEGVYGIFNSVLFDNICPTPILQKKPSTEQPLYSSSLWGPAVDGCD
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_001 EENGSTSKTIVYHLDEGVYGIFNSVLFDNICPTPILQKKPSTEQPLYSSSLWGPAVDGCD
              220       230       240       250       260       270

         370       380       390       400       410       420     
pF1KE6 CVAEGLWLPQLHVGDWLVFDNMGAYTVGMGSPFWGTQACHITYAMSRVAWEALRRQLMAA
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_001 CVAEGLWLPQLHVGDWLVFDNMGAYTVGMGSPFWGTQACHITYAMSRVAWEALRRQLMAA
              280       290       300       310       320       330

         430       440       450       460
pF1KE6 EQEDDVEGVCKPLSCGWEITDTLCVGPVFTPASIM
       :::::::::::::::::::::::::::::::::::
NP_001 EQEDDVEGVCKPLSCGWEITDTLCVGPVFTPASIM
              340       350       360     

>>XP_016855657 (OMIM: 608353) PREDICTED: antizyme inhibi  (365 aa)
 initn: 2492 init1: 2492 opt: 2492  Z-score: 3097.6  bits: 582.1 E(85289): 8.4e-166
Smith-Waterman score: 2492; 100.0% identity (100.0% similar) in 365 aa overlap (96-460:1-365)

          70        80        90       100       110       120     
pF1KE6 FYAVKCNSSPGVLKVLAQLGLGFSCANKAEMELVQHIGIPASKIICANPCKQIAQIKYAA
                                     ::::::::::::::::::::::::::::::
XP_016                               MELVQHIGIPASKIICANPCKQIAQIKYAA
                                             10        20        30

         130       140       150       160       170       180     
pF1KE6 KHGIQLLSFDNEMELAKVVKSHPSAKMVLCIATDDSHSLSCLSLKFGVSLKSCRHLLENA
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 KHGIQLLSFDNEMELAKVVKSHPSAKMVLCIATDDSHSLSCLSLKFGVSLKSCRHLLENA
               40        50        60        70        80        90

         190       200       210       220       230       240     
pF1KE6 KKHHVEVVGVSFHIGSGCPDPQAYAQSIADARLVFEMGTELGHKMHVLDLGGGFPGTEGA
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 KKHHVEVVGVSFHIGSGCPDPQAYAQSIADARLVFEMGTELGHKMHVLDLGGGFPGTEGA
              100       110       120       130       140       150

         250       260       270       280       290       300     
pF1KE6 KVRFEEIASVINSALDLYFPEGCGVDIFAELGRYYVTSAFTVAVSIIAKKEVLLDQPGRE
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 KVRFEEIASVINSALDLYFPEGCGVDIFAELGRYYVTSAFTVAVSIIAKKEVLLDQPGRE
              160       170       180       190       200       210

         310       320       330       340       350       360     
pF1KE6 EENGSTSKTIVYHLDEGVYGIFNSVLFDNICPTPILQKKPSTEQPLYSSSLWGPAVDGCD
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 EENGSTSKTIVYHLDEGVYGIFNSVLFDNICPTPILQKKPSTEQPLYSSSLWGPAVDGCD
              220       230       240       250       260       270

         370       380       390       400       410       420     
pF1KE6 CVAEGLWLPQLHVGDWLVFDNMGAYTVGMGSPFWGTQACHITYAMSRVAWEALRRQLMAA
       ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 CVAEGLWLPQLHVGDWLVFDNMGAYTVGMGSPFWGTQACHITYAMSRVAWEALRRQLMAA
              280       290       300       310       320       330

         430       440       450       460
pF1KE6 EQEDDVEGVCKPLSCGWEITDTLCVGPVFTPASIM
       :::::::::::::::::::::::::::::::::::
XP_016 EQEDDVEGVCKPLSCGWEITDTLCVGPVFTPASIM
              340       350       360     




460 residues in 1 query   sequences
60827320 residues in 85289 library sequences
 Tcomplib [36.3.4 Apr, 2011] (8 proc)
 start: Tue Nov  8 03:23:30 2016 done: Tue Nov  8 03:23:32 2016
 Total Scan time:  9.220 Total Display time:  0.070

Function used was FASTA [36.3.4 Apr, 2011]
Inquiries or Suggestions ?
Send a message to flexiclone AT kazusagt.com